ProCE Banner Activity

Treatment of Relapsed/Refractory CLL/SLL

Slideset Download
Conference Coverage
Download these slides from an expert-led symposium on the use of BTK inhibitors in relapsed/refractory CLL/SLL.

Released: December 09, 2022

Expiration: December 08, 2023

No longer available for credit.
Begin Activity

Share

Faculty

Jeffrey P. DONOTUSESharman

Jeffrey P. DONOTUSESharman, MD

Medical Oncologist
Willamette Valley Cancer Institute and Research Center
Springfield, Oregon

Provided by

Provided by Clinical Care Options, LLC.
ProCE Banner

Supporters

BeiGene Ltd

Lilly

Program Director Disclosure

Program Director

Jeffrey P. DONOTUSESharman, MD

Medical Oncologist
Willamette Valley Cancer Institute and Research Center
Springfield, Oregon